Copatient
acquired by MebexBoston, US · Founded 2012 · 1 known investors
Medical billing advocacy platform identifying errors and appealing insurance denials. Acquired by Mebex.
Founders & leadership
KV
Katherine VahleNamed on SEC filing
RP
Rebecca PalmNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$3.6M disclosed across 1 round · 2014
▶$3.6MraisedSep 2014 · 9 investors · Other TechnologyRule 506(b)
▶$3.6MraisedSep 2014 · 9 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Katherine VahleDirector, Promoter
- Rebecca PalmExecutive Officer, Director
- Offering amount
- $3.6M
- Amount sold
- $3.6M
- First sale
- May 2014
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Copatient do?
- Medical billing advocacy platform identifying errors and appealing insurance denials. Acquired by Mebex.
- Who are Copatient's investors?
- Copatient's investors include .406 Ventures.
- How much funding has Copatient raised?
- Copatient has disclosed $3.6M raised across 1 round.
- Who acquired Copatient?
- Copatient was acquired by Mebex.
- Where is Copatient headquartered?
- Copatient is headquartered in Boston, US.